Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial

Kieran Lee; Victoria Carter; Derek Skinner; Kai M Beeh; James Chalmers; Allan Clark; David MG  Halpin; Nasir  Hannan; Alan Kaplan; Konstantinos  Kostikas; Hilary Pinnock; Nicolas Roche; Omar Usmani; Job F. M.  van Boven; Paul  Mastoridis; Rupert  Jones; David Price

Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial

Kieran Lee, Victoria Carter, Derek Skinner, Kai M Beeh, James Chalmers, Allan Clark, David MG Halpin, Nasir Hannan, Alan Kaplan, Konstantinos Kostikas, Hilary Pinnock, Nicolas Roche, Omar Usmani, Job F. M. van Boven, Paul Mastoridis, Rupert Jones, David Price

Research output: Contribution to conference › Abstract › peer-review

Abstract

Commonly prescribed maintenance inhaled therapies for the treatment of COPD have been shown to reduce the risk of exacerbations

Original language	English
Publication status	Accepted/In press - 14 Aug 2021
Event	PCRS Respiratory Conference 2021 - Virtual Conference Duration: 24 Sep 2021 → 25 Sep 2021 https://www.pcrs-uk.org/annual-conference

Conference

Conference	PCRS Respiratory Conference 2021
Abbreviated title	PCRS 2021
Period	24/09/21 → 25/09/21
Internet address	https://www.pcrs-uk.org/annual-conference

Cite this

Lee, K., Carter, V., Skinner, D., Beeh, K. M., Chalmers, J., Clark, A., Halpin, D. MG., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J. F. M., Mastoridis, P., Jones, R., & Price, D. (Accepted/In press). Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial. Abstract from PCRS Respiratory Conference 2021.

Lee, K, Carter, V, Skinner, D, Beeh, KM, Chalmers, J, Clark, A, Halpin, DMG, Hannan, N, Kaplan, A, Kostikas, K, Pinnock, H, Roche, N, Usmani, O, van Boven, JFM, Mastoridis, P, Jones, R & Price, D 2021, 'Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial', PCRS Respiratory Conference 2021, 24/09/21 - 25/09/21.

@conference{71104f78d5e24ea2ba65d2e0743cb16a,

title = "Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial",

abstract = "Commonly prescribed maintenance inhaled therapies for the treatment of COPD have been shown to reduce the risk of exacerbations",

author = "Kieran Lee and Victoria Carter and Derek Skinner and Beeh, {Kai M} and James Chalmers and Allan Clark and Halpin, {David MG} and Nasir Hannan and Alan Kaplan and Konstantinos Kostikas and Hilary Pinnock and Nicolas Roche and Omar Usmani and {van Boven}, {Job F. M.} and Paul Mastoridis and Rupert Jones and David Price",

year = "2021",

month = aug,

day = "14",

language = "English",

note = "PCRS Respiratory Conference 2021, PCRS 2021 ; Conference date: 24-09-2021 Through 25-09-2021",

url = "https://www.pcrs-uk.org/annual-conference",

}

TY - CONF

T1 - Poor adherence in exacerbating COPD patients

T2 - PCRS Respiratory Conference 2021

AU - Lee, Kieran

AU - Carter, Victoria

AU - Skinner, Derek

AU - Beeh, Kai M

AU - Chalmers, James

AU - Clark, Allan

AU - Halpin, David MG

AU - Hannan, Nasir

AU - Kaplan, Alan

AU - Kostikas, Konstantinos

AU - Pinnock, Hilary

AU - Roche, Nicolas

AU - Usmani, Omar

AU - van Boven, Job F. M.

AU - Mastoridis, Paul

AU - Jones, Rupert

AU - Price, David

PY - 2021/8/14

Y1 - 2021/8/14

N2 - Commonly prescribed maintenance inhaled therapies for the treatment of COPD have been shown to reduce the risk of exacerbations

AB - Commonly prescribed maintenance inhaled therapies for the treatment of COPD have been shown to reduce the risk of exacerbations

M3 - Abstract

Y2 - 24 September 2021 through 25 September 2021

ER -

Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial

Abstract

Conference

Fingerprint

Cite this